# Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

> **NCT01165476** · PHASE1 · COMPLETED · sponsor: **United Therapeutics** · enrollment: 64 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Treprostinil diethanolamine

## Key facts

- **NCT ID:** NCT01165476
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2011-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165476, "Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01165476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
